Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis

Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation

(2022) Laura Hauffe et al.   Cell Death Discovery

Tepotinib: First Approval

(2020) Anthony Markham   DRUGS

Treatment of muscle‐invasive and advanced bladder cancer in 2020

(2020) Vaibhav G. Patel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Role of tyrosine phosphorylation in modulating cancer cell metabolism

(2020) Maria Letizia Taddei et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Bladder Cancer

(2020) Andrew T. Lenis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

(2020) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer

(2019) Alexandria C. Rutkovsky et al.   BMC CANCER

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

C-Jun drives melanoma progression in PTEN wild type melanoma cells

(2019) Melanie Kappelmann-Fenzl et al.   Cell Death & Disease

Novel natural compounds from endophytic fungi with anticancer activity

(2018) Shou-Jie Li et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

OUP accepted manuscript

(2018)   NUCLEIC ACIDS RESEARCH

Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1

(2018) Lihong Wang-Bishop et al.   GASTROENTEROLOGY

Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs

(2018) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance

(2018) Bowen Xie et al.   CANCER LETTERS

Bladder cancer

(2017) Oner Sanli et al.   Nature Reviews Disease Primers

The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy

(2015) Michael Goldstein et al.   Annual Review of Medicine

miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer

(2015) C. Cai et al.   CLINICAL CANCER RESEARCH

The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes

(2015) Martin Fischer et al.   NUCLEIC ACIDS RESEARCH

EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma

(2015) Yin-Lian Cha et al.   PLoS One

AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma

(2013) Melanie Kappelmann et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

c-Jun, at the crossroad of the signaling network

(2011) Qinghang Meng et al.   Protein & Cell